Consequently, CHK1 may play an important role in the resistance of tumor cells to genotoxic therapy, raising the possibility that inhibitors of checkpoint kinases may be useful adjuvant agents in chemotherapy of cancer. The gene discussed is CHEK1; the disease is cancer.